Apyx Medical (APYX) Competitors $1.19 -0.13 (-9.85%) Closing price 04:00 PM EasternExtended Trading$1.24 +0.05 (+4.20%) As of 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends APYX vs. NVRO, SKIN, DRTS, CATX, BWAY, OBIO, KRMD, TLSI, INFU, and STIMShould you be buying Apyx Medical stock or one of its competitors? The main competitors of Apyx Medical include Nevro (NVRO), Beauty Health (SKIN), Alpha Tau Medical (DRTS), Perspective Therapeutics (CATX), BrainsWay (BWAY), Orchestra BioMed (OBIO), KORU Medical Systems (KRMD), TriSalus Life Sciences (TLSI), InfuSystem (INFU), and Neuronetics (STIM). These companies are all part of the "medical equipment" industry. Apyx Medical vs. Nevro Beauty Health Alpha Tau Medical Perspective Therapeutics BrainsWay Orchestra BioMed KORU Medical Systems TriSalus Life Sciences InfuSystem Neuronetics Apyx Medical (NASDAQ:APYX) and Nevro (NYSE:NVRO) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk. Do analysts rate APYX or NVRO? Nevro has a consensus price target of $6.43, suggesting a potential upside of 12.03%. Given Nevro's higher probable upside, analysts plainly believe Nevro is more favorable than Apyx Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67Nevro 2 Sell rating(s) 10 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.92 Does the MarketBeat Community prefer APYX or NVRO? Nevro received 426 more outperform votes than Apyx Medical when rated by MarketBeat users. Likewise, 62.84% of users gave Nevro an outperform vote while only 60.94% of users gave Apyx Medical an outperform vote. CompanyUnderperformOutperformApyx MedicalOutperform Votes7860.94% Underperform Votes5039.06% NevroOutperform Votes50462.84% Underperform Votes29837.16% Which has more volatility & risk, APYX or NVRO? Apyx Medical has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500. Comparatively, Nevro has a beta of 0.94, indicating that its share price is 6% less volatile than the S&P 500. Is APYX or NVRO more profitable? Nevro has a net margin of -16.54% compared to Apyx Medical's net margin of -58.59%. Nevro's return on equity of -23.52% beat Apyx Medical's return on equity.Company Net Margins Return on Equity Return on Assets Apyx Medical-58.59% -137.98% -36.74% Nevro -16.54%-23.52%-10.83% Which has preferable earnings and valuation, APYX or NVRO? Apyx Medical has higher earnings, but lower revenue than Nevro. Nevro is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApyx Medical$48.54M0.92-$18.71M-$0.83-1.43Nevro$419.15M0.51-$92.21M-$1.89-3.03 Does the media refer more to APYX or NVRO? In the previous week, Nevro had 5 more articles in the media than Apyx Medical. MarketBeat recorded 7 mentions for Nevro and 2 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 1.16 beat Nevro's score of 0.85 indicating that Apyx Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apyx Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nevro 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals hold more shares of APYX or NVRO? 55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 95.5% of Nevro shares are held by institutional investors. 16.8% of Apyx Medical shares are held by company insiders. Comparatively, 3.2% of Nevro shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryNevro beats Apyx Medical on 10 of the 19 factors compared between the two stocks. Get Apyx Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APYX vs. The Competition Export to ExcelMetricApyx MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$44.80M$4.54B$5.79B$8.36BDividend YieldN/A39.81%4.89%3.97%P/E Ratio-1.4329.9524.8919.11Price / Sales0.9249.46373.96113.79Price / CashN/A51.0838.0534.62Price / Book1.536.237.334.26Net Income-$18.71M$67.64M$3.18B$246.62M7 Day Performance-16.20%-5.90%-3.31%-3.85%1 Month Performance-18.21%-9.97%-7.14%-6.96%1 Year Performance-44.13%10.53%12.21%3.36% Apyx Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APYXApyx Medical2.2639 of 5 stars$1.19-9.8%N/A-36.5%$44.80M$48.54M-1.43270Positive NewsGap DownNVRONevro2.7277 of 5 stars$5.73-0.1%$6.43+12.2%-59.7%$214.53M$419.15M-3.031,215Earnings ReportShort Interest ↓SKINBeauty Health1.7126 of 5 stars$1.56-3.1%$2.55+63.5%-65.8%$193.63M$398M-3.711,030Positive NewsDRTSAlpha Tau Medical2.7648 of 5 stars$2.74+2.2%$8.00+192.0%-3.0%$191.58MN/A-6.3780CATXPerspective Therapeutics1.8015 of 5 stars$2.73-1.1%$15.14+454.7%N/A$184.52M$1.43M0.0070News CoverageGap DownBWAYBrainsWay2.974 of 5 stars$9.78-9.0%$13.17+34.6%+42.4%$184.02M$38.63M97.81120Upcoming EarningsShort Interest ↑News CoverageHigh Trading VolumeOBIOOrchestra BioMed2.3338 of 5 stars$4.78+1.3%$16.25+240.0%-40.2%$181.69M$2.76M-2.974Positive NewsGap DownKRMDKORU Medical Systems3.1512 of 5 stars$3.69-0.5%$4.70+27.4%+56.4%$170.06M$31.99M-14.7680Gap DownTLSITriSalus Life Sciences3.4427 of 5 stars$5.51-4.5%$11.56+109.8%-39.4%$168.02M$26.89M-2.21106Short Interest ↑News CoverageINFUInfuSystem1.5408 of 5 stars$7.56-1.2%$13.00+72.0%N/A$160.73M$125.79M126.02410News CoverageGap DownSTIMNeuronetics0.7774 of 5 stars$4.46+8.0%$4.67+4.6%+41.5%$135.35M$72.71M-3.63180Earnings ReportShort Interest ↑News CoverageGap Up Related Companies and Tools Related Companies NVRO Competitors SKIN Competitors DRTS Competitors CATX Competitors BWAY Competitors OBIO Competitors KRMD Competitors TLSI Competitors INFU Competitors STIM Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:APYX) was last updated on 3/4/2025 by MarketBeat.com Staff From Our Partners77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apyx Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apyx Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.